Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Grossman

Showing results (121-130 of 171) with videos related to

Pageof 18
Sort By:
Journal of Neuro-Oncology|April 12, 2012
Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomasHatim Husain, William Savage, Stuart A Grossman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochlorideStuart A Grossman, Kathryn A Carson, Tracy T Batchelor, et al.
Neuro-Oncology|January 19, 2013
NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiformeDavid M Peereboom, Manmeet S Ahluwalia, Xiaobu Ye, et al.
Frontiers in Medicine|December 25, 2023
Druggable genomic landscapes of high-grade gliomasPaola Ghanem, Maria Fatteh, David Olayinka Kamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trialJon Weingart, Stuart A Grossman, Kathryn A Carson, et al.
Journal of Neuro-Oncology|May 8, 2010
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomasDavid M Peereboom, Jeffrey G Supko, Kathryn A Carson, et al.
Neuro-Oncology Advances|April 14, 2025
Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomasStuart A Grossman, Carlos G Romo, Xiaobu Ye, et al.
Journal of Neuro-Oncology|November 11, 2018
The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastomaMatthias Holdhoff, Xiaobu Ye, Anna F Piotrowski, et al.
Cancer|April 21, 2012
A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)L Burt Nabors, Thomas Mikkelsen, Monika E Hegi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed GlioblastomaJaishri O Blakeley, Stuart A Grossman, Andrew S Chi, et al.
Pageof 18

Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
Journal of Neuro-Oncology|April 12, 2012
Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomasHatim Husain, William Savage, Stuart A Grossman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochlorideStuart A Grossman, Kathryn A Carson, Tracy T Batchelor, et al.
Neuro-Oncology|January 19, 2013
NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiformeDavid M Peereboom, Manmeet S Ahluwalia, Xiaobu Ye, et al.
Frontiers in Medicine|December 25, 2023
Druggable genomic landscapes of high-grade gliomasPaola Ghanem, Maria Fatteh, David Olayinka Kamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trialJon Weingart, Stuart A Grossman, Kathryn A Carson, et al.
Journal of Neuro-Oncology|May 8, 2010
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomasDavid M Peereboom, Jeffrey G Supko, Kathryn A Carson, et al.
Neuro-Oncology Advances|April 14, 2025
Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomasStuart A Grossman, Carlos G Romo, Xiaobu Ye, et al.
Journal of Neuro-Oncology|November 11, 2018
The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastomaMatthias Holdhoff, Xiaobu Ye, Anna F Piotrowski, et al.
Cancer|April 21, 2012
A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)L Burt Nabors, Thomas Mikkelsen, Monika E Hegi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed GlioblastomaJaishri O Blakeley, Stuart A Grossman, Andrew S Chi, et al.
Pageof 18